Annual Symposium on Health Law & Policy
Tenth Annual Symposium on Health Law & Policy
Innovations and Incentives in Life Sciences
Presented by the Beazley Institute for Health Law and Policy and Annals of Health Law
October 28, 2016
Loyola University Chicago School of Law
Philip H. Corboy Law Center
Power Rogers & Smith Ceremonial Courtroom
25 E. Pearson Street
The conference will be held in the Philip H. Corboy Law Center, Power Rogers & Smith Ceremonial Courtroom, on the 10th floor of 25 E. Pearson St. at Loyola University Chicago’s Water Tower Campus.
To register and view the conference agenda please visit our registration page.
Loyola is pleased to present this program free of charge to attendees not seeking CLE credit.
For those who wish to obtain credit, registration fees will apply as follows:
- $50 for attendees seeking CLE credit
- $40 for Loyola alumni seeking CLE credit
- As part of our wider financial hardship consideration, there is an immediate discount of 50% for attorneys working the areas of government or public interest.
- There is no charge for CLE credit for Loyola Law faculty, staff, or students.
- CLE fees are payable at the door by cash or check made payable to Loyola University Chicago.
About the Symposium
Loyola University Chicago School of Law’s Tenth Annual Symposium on Health Law and Policy will explore Innovations and Incentives in Life Science, and discuss industry and stakeholder responses to those innovations and corresponding regulations.
The Symposium will feature distinguished faculty, researchers and industry representatives. The Symposium will feature a keynote speaker discussing Medicare "coverage with evidence development" as a way to promote diagnostics development in the face of dubious patent protection and looming regulatory burdens. Next, the Symposium will examine the intersection of innovations in life sciences and patient access including innovations in Biopharma in the wake of public health outbreaks such as Ziki and Ebola and explore the impacts of biosimilar legislation being implemented across the country. The Symposium will discuss the scientific, regulatory and ethical implications of gene editing and gene editing technology. Finally, the Symposium will discuss innovations in medical device and mHealth including 3-D Bioprinting and interagency coordination on mHealth.
About ANNALS OF HEALTH LAW
Twice yearly (Winter and Summer) the Beazley Institute for Health Law and Policy publishes Annals of Health Law, The Health Policy and Law Review of Loyola University Chicago. Annals contains articles of general interest in health law, which are deemed by the editors to make a contribution to the teaching, practice, and/or public policy surrounding health law. Past volumes have focused on corporate, regulatory, bioethical, and pharmaceutical issues, as well as patient rights and advocacy. Through this publication, health law students are afforded the opportunity to edit a law review article.
Advance Directive is an online publication of Annals of Health Law, which is also published twice yearly (Fall and Spring). Similar to Annals, Advance Directive publishes articles that provide insight into the divergent areas of health law. Advance Directive allows health law students to write short articles regarding current health law topics, which are often at the crux of debate amongst legislators, practitioners, and academics.
9:00-9:15am: Welcome and Introduction
- Michael Kaufman, interim dean and professor of law, Loyola University Chicago School of Law
- Lawrence Singer, associate dean of online Learning; director of the Beazley Institute for Health Law and Policy, Loyola University Chicago School of Law
9:15-10:15am: Special Address Promoting Diagnostics Development through Medicare Coverage with Evidence Development
- Rebecca Eisenberg, Robert and Barbara Luciano Professor of Law, University of Michigan School of Law
10:15-10:30am: Break (coffee replenished)
10:30-11:50pm: Session 1 Mobile Health and Devices
- Rachel E. Sachs, associate professor of law at the Washington University in St. Louis School of Law
- Tabrez Y. Ebrahim, attorney at Bracewell, LLP
- Janet Trunzo, senior executive vice president, Technology & Regulatory Affairs, Advanced Medical Technology Association
11:50-12:20pm: Break for Lunch
12:20-1:40pm: Session 2 Scientific, Regulatory, and Ethical Issues Surrounding Gene Editing Technology
- Barry Furrow, professor and director of the Health Law Program at Drexel University School of Law
- Barbara Evans, professor and director of the Center on Biotechnology & Law at University of Houston Law Center
- Laurie Zoloth, professor and director of the Center for Bioethics, Science and Society at the Feinberg School of Medicine
1:40-1:55pm: Break (afternoon snack)
1:55-3:15pm: Session 3 Innovation and Patient Access
- Ana Santos Rutschman, Jaharis Faculty Fellow in Health Law and Intellectual Property at DePaul University College of Law
- Sam Halabi, associate professor for the College of Law at The University of Tulsa
- Katherine A. Macfarlane, associate professor of Law at the University of Idaho College of Law
3:15-3:30pm: Closing Remarks & Reflections
*Session 1-3 are broken down by time as follows: 5 minute introductions, 15 minutes per speaker and 30 minute moderated Q & A
Rebecca S. Eisenberg, is the Robert and Barbara Luciano Professor of Law at University of Michigan School of Law. She specializes in patent law and the regulation of biopharmaceutical innovation. She has written and lectured extensively about the role of intellectual property in biopharmaceutical research, publishing in leading law reviews and scientific journals. She is a graduate of Stanford University and Boalt Hall School of Law at the University of California, Berkeley. She served as law clerk for the Hon. Robert F. Peckham of the U.S. District Court for the Northern District of California and practiced law as a litigator in San Francisco.
Rachel Sachs is an associate professor of law at the Washington University in St. Louis School of Law. She is a scholar of innovation policy whose work explores the interaction of intellectual property law, food and drug regulation, and health law. Prior to joining the faculty, Professor Sachs was an Academic Fellow at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics and a Lecturer in Law at Harvard Law School. She clerked for the Hon. Richard A. Posner of the U.S. Court of Appeals for the Seventh Circuit. She received her JD from Harvard Law School, a Master of Public Health from the Harvard School of Public Health and her AB in Bioethics from Princeton University.
Tabrez Ebrahim is an Intellectual Property attorney at Bracewell LLP. His practice focuses on patent prosecution, outsourcing and information technology contracts, and technology transactions. He also advises clients on the financing and formation of startups and spin-outs, and is a frequent speaker on legal and business issues related to 3D printing. Previously as a R&D engineer, he was an inventor on patents for flexible display devices. Tabrez holds JD & MBA degrees from Northwestern University and a LLM degree from the University of Houston Law Center.
Janet E. Trunzo is Senior Executive Vice President, Technology and Regulatory Affairs for the Advanced Medical Technology Association (AdvaMed) and leads a team of regulatory experts. During her tenure at AdvaMed, she focused on the passage of the Medical Device User Fee and Modernization Act of 2002 (MDUFMA), its reauthorization in 2007 and the subsequent negotiation for MDUFA III. She also represented the U. S. device industry on the Global Harmonization Task Force. Prior to joining AdvaMed, she held positions at a medical device and diagnostics manufacturer and a hospital, diagnostic clinic and research institute. Trunzo received her MS in health physics from Rutgers University and her BS in Chemistry from California University of Pennsylvania.
Professor Zoloth is a Charles McCormick Deering Professor of Teaching Excellence at Northwestern University. Her research is in the area of bioethics; religion and science; feminist ethics, post-modern Jewish philosophy and Jewish ethics. She was the founding director of both the Brady Program in Ethics and Civic Life in Weinberg College and the Center for Bioethics, Science, and Society at Feinberg School of Medicine. She previously served as Professor of Ethics and Director of the Program in Jewish Studies at San Francisco State University. As a clinical bioethicist, she helped create the National Kaiser Permanente Bioethics committees, and worked for a decade at the East Bay Children’s Hospital. She was the founding chair of the Howard Hughes Medical Institute, Bioethics Advisory Board.
Ana Santos Rutschman is the 2016-2017 Jaharis Faculty Fellow in Health Law and Intellectual Property. Her primary research and teaching interests include intellectual property, health law, incentives theory and innovation policy in the life sciences. Professor Santos Rutschman has been working on the intellectual property-related aspects of the development and licensing of the Ebola and Zika vaccines, having recently consulted for the World Health Organization on this topic. Prior to joining DePaul, she was the co-director for Global Healthcare Innovation Alliances at Duke University. Professor Santos Rutschman received an LLM from Duke, and is completing her doctoral degree in intellectual property.
Sam Halabi is a scholar of national and global health law with a specialization in health services and pharmaceutical business organizations. He serves as a Scholar at the O’Neill Institute for National and Global Health Law at Georgetown University, and advisor to the Lancet-Georgetown University Commission on Global Health and Law. Before earning his JD from Harvard Law School, Professor Halabi was awarded a British Marshall scholarship to study in the UK where he earned an MPhil from the University of Oxford (St. Antony’s College). He served as a Rotary International Ambassadorial Scholar at the American University of Beirut and earned first prize in the Elie Wiesel Foundation for Humanity’s Essay in Ethics in 1999.
Professor Katherine Macfarlane is a professor of law at the University of Idaho College of Law. She received her BA from Northwestern University, and her JD from Loyola Law School, Los Angeles. Before joining the University of Idaho, she taught Civil Rights Litigation, Disability Rights and Legal Writing at LSU’s Hebert Law Center. Professor Macfarlane also worked as an assistant corporation counsel in the New York City Law Department’s Special Federal Litigation Division, and as an associate at Quinn Emanuel. She clerked for the District of Arizona and for the U.S. Court of Appeals for the Ninth Circuit.
Barbara J. Evans PhD, JD, LLM is the Alumnae College Professor of Law and director of the Center for Biotechnology & Law at University of Houston Law Center. Her research includes health information systems, genomic testing, gene editing, and precision medicine. She was a Greenwall Foundation Faculty Scholar in Bioethics and is a member of the American Law Institute. She currently serves on the National Academies’ Committee on Future Biotechnology Products; the Institute of Medicine’s Committee on Accessible and Affordable Hearing Health Care for Adults; the FDA’s Sentinel System Privacy Panel, Patient Engagement Working Group, and the National Committee for Vital and Health Statistics.
Barry R. Furrow is a professor of law and director of the Health Law Program at the Thomas R. Kline School of Law, Drexel University. He was educated at Harvard College and Harvard Law School. Professor Furrow’s research includes patient safety, hospital liability, bioethics, legal issues of pain management, and health care regulation. He was the lead author of the first casebook to use “health law” to describe the growing field. Now in its 7th edition, the book has been used in more than 150 universities and has been cited more than 500 times in scholarly articles and court opinions. Furrow is also co-author of the treatise, Health Law, which has been cited by the U.S. Supreme Court three times.